Given the high sensitivity and specificity from recent studies and the current study 7, which is being tested amongst some very reputable hospitals and specialists, this next step into the US is fairly indicative of their level of confidence in the results of study 7 I would have thought. All indications is that we are moving forward as planned and I’m expecting some very good outcomes from this final study.
Ann: Rhythm Establishes US Entity To Drive US Expansion Strategy, page-4
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $29.83M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.5¢ | 11.5¢ | $43.69K | 363.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32816 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 111491 | 2 |
View Market Depth
| Last trade - 13.43pm 11/11/2024 (20 minute delay) ? |
| RHY (ASX) Chart |